GlassScriptPhysician profile
Brad M Hirsch
NPI 1184986523
$1,309.81
in general payments reported to CMS, 2019-2025
20 companies · $19.65 in 2025
The $19.65 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,085 · 2020: $167 · 2023: $20.86 · 2024: $17.83 · 2025: $19.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $58.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $58.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $191.44 | 2019-2024 | Ozempic, Rybelsus |
| Lilly USA, LLC | $181.05 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $149.08 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $144.81 | 2019 | |
| Pfizer INC. | $114.44 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $78.23 | 2019 | |
| Sanofi Pasteur INC. | $49.51 | 2019-2023 | |
| Amgen INC. | $47.51 | 2019 | |
| Nalpropion Pharmaceuticals LLC | $44.27 | 2019 | |
| Allergan, INC. | $43.45 | 2019-2020 | |
| Eisai INC. | $40.07 | 2019 | |
| Neos Therapeutics, LP | $39.36 | 2019-2020 | |
| Amarin Pharma, INC. | $36.28 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $35.98 | 2019 | |
| Janssen Pharmaceuticals, INC | $35.84 | 2019-2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $19.65 | 2025 | The Cologuard Plus Collection Kit |
| Astellas Pharma US INC | $18.78 | 2019 | |
| Merck Sharp & Dohme LLC | $15.13 | 2019 | |
| Novartis Pharmaceuticals Corporation | $13.64 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.29 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brad Hirsch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.